TP53 and squamous cell carcinoma: Future investigations are warranted to integrate genetic TP53 mutations15 and P16 overexpression43 and radiomics data to characterize squamous cell carcinoma of the head and neck and provide an alternative non-invasive, multi-modal approach to OSCC outcome predictions.